SOMNOMED APPOINTS NEW HEAD FOR NORTH AMERICAN REGION
27th September 2012: SomnoMed announced today
the appointment of Kien T. Nguyen as President for
SomnoMed Inc., the US subsidiary of SomnoMed Limited.
Kien has a lifelong career in the healthcare industry,
working for leading companies such as Stryker Corporation,
Kinetic Concepts, Inc. (KCI) and various medical device
divisions of Johnson & Johnson. Most recently, he was Vice
President and General Manager of OtisMed, a business unit of
Stryker Orthopaedics, a division of the $8 billion Stryker
Corporation. At KCI, he fulfilled various functional Vice
President positions, including Global Portfolio Management,
Global Research & Ideation, and Global Marketing of the
Active Healing Solutions division, with revenues
responsibilities of $1.4 billion. Most of his earlier career
was spent with Ethicon, Inc., a Johnson & Johnson company,
where he held roles in product development, product
marketing, clinical sales and finally as Worldwide Marketing
Director for the biosurgical business unit within Johnson &
Johnson Wound Management.
"We are very pleased to have been able to gain Kien Nguyen as
our new head of our North American business. Kien is an
outstanding individual with an impeccable career, focused on
strategy development and marketing & sales in medical devices
and biological products. His academic background is exemplary
with an MBA from Columbia Business School, a doctorate
(Neuroscience) from University of Colorado and a Master of
Science (Microbiology) from Minnesota State University. His
past business successes were based on solid knowledge of the
key factors influencing medical specialists and decision
makers and his great personality allowing him to attract
talent around him and lead a team to success," said Dr. Peter
Neustadt, Executive Chairman of SomnoMed Limited.
"This appointment is significant for SomnoMed's business in
the US and Canada, being our most important markets. Kien
will work closely with me and report to SomnoMed's board on a
monthly basis. Over the last three months all directors were
directly involved in the recruitment of the President for
SomnoMed Inc. and the quality of executives interviewed was
outstanding. After an extensive search process all directors
were of the opinion that Kien was the candidate of choice and
the executive most likely to succeed in building a
significant business for our company in North America in the
future," said Dr. Neustadt.
Kien was born in Vietnam and came to the US as a young child.
As a refugee of the war, he had to take early responsibility
for his education, putting himself through college working as
a surgical technician at the Mayo Clinic, and earning a
Bachelor of Science degree in Genetics and Cell Biology from
the University of Minnesota. Post baccalaureate, he joined
Lark Sequencing Technologies, Inc., as a molecular biologist.
He is married and has two sons.
Kien Nguyen will be based at the North American head office
in Frisco, TX. His appointment will take effect on 5 November
SomnoMed is a public company providing diagnostic and
treatment solutions for Sleep-related Breathing Disorders
including obstructive sleep apnea, snoring and bruxism.
SomnoMed was commercialized on the basis of extensive
clinical research. Supporting independent clinical research,
continuous innovation and instituting medical manufacturing
standards has resulted in SomnoDent® becoming
the state-of-the-art and clinically proven medical oral
appliance therapy for obstructive sleep apnea.
SomnoDent® is the most comfortable and effective
design and treatment solution for over 100,000 patients in 22
countries. For additional information, visit SomnoMed at